Literature DB >> 22694877

Incidence and characteristics of asymptomatic distal deep vein thrombosis unexpectedly found at admission in an Internal Medicine setting.

Gabriele Ciuti1, Elisa Grifoni, Andrea Pavellini, Daniele Righi, Riccardo Livi, Federico Perfetto, Rosanna Abbate, Domenico Prisco, Alberto Moggi Pignone.   

Abstract

INTRODUCTION: Lower limb deep vein thrombosis (DVT) is the most frequent clinical manifestation of venous thromboembolism (VTE) and can involve proximal or distal veins. Distal DVT (dDVT) is often asymptomatic and data about its incidence and prognosis are scanty, especially in high risk medical inpatients. Therefore, no consensus exists on the value of detecting and treating dDVTs. Aim of study was to evaluate incidence and characteristics of asymptomatic isolated dDVT at admission in an Internal Medicine department.
MATERIALS AND METHODS: Consecutive patients hospitalized for acute medical illnesses, in whom VTE was not the admission diagnosis, underwent Doppler Ultrasonography. For all patients with dDVT standard treatment with therapeutic doses of low molecular weight heparin or fondaparinux was proposed. Follow-up visits were scheduled at 1, 6 and 12weeks.
RESULTS: One-hundred-fifty-four patients were enrolled. In 4.5% a proximal DVT and in 16.2% an asymptomatic dDVT were found. Female sex, elevated age and renal and electrolyte abnormalities were significantly associated to dDVT (p=0.014, p=0.009 and p=0.046, respectively). Only low degree of mobility (LDM) was independently associated to dDVT [OR 7.97 (95%CI 2.42-26.27), p=0.001)]. A high mortality rate, not for VTE-related causes, was found, especially in the first week, among dDVT patients.
CONCLUSIONS: We found a high incidence of clinically silent dDVTs. LDM evaluation could be useful to select patients at high risk in whom to perform a search for dDVT.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22694877     DOI: 10.1016/j.thromres.2012.05.018

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  4 in total

1.  Prevalence of Acute Deep Vein Thrombosis in Patients with Ankle and Foot Fractures Treated with Nonoperative Management-A Pilot Study.

Authors:  Edward Ho; Abdullah Omari
Journal:  Int J Angiol       Date:  2015-07-10

2.  Incidence of asymptomatic deep vein thrombosis in patients with COVID-19 pneumonia and elevated D-dimer levels.

Authors:  P Demelo-Rodríguez; E Cervilla-Muñoz; L Ordieres-Ortega; A Parra-Virto; M Toledano-Macías; N Toledo-Samaniego; A García-García; I García-Fernández-Bravo; Z Ji; J de-Miguel-Diez; L A Álvarez-Sala-Walther; J Del-Toro-Cervera; F Galeano-Valle
Journal:  Thromb Res       Date:  2020-05-13       Impact factor: 3.944

3.  Incidence, risk factors, clinical characteristics and outcomes of deep venous thrombosis in patients with COVID-19 attending the Emergency Department: results of the UMC-19-S8.

Authors:  Sònia Jiménez; Òscar Miró; Pere Llorens; Francisco J Martín-Sánchez; Guillermo Burillo-Putze; Pascual Piñera; Alfonso Martín; Aitor Alquézar; Eric J García-Lamberechts; Javier Jacob; María L L Grima; Javier Millán; Francisca Molina; Patricia B Albero; Carlos Cardozo; Josep M Mòdol; Alfons Aguirre; Ruth Gaya; María Adroher; Lluís Llauger; Juan J L Díaz; Nayra C González; Paula L Aragües; Ana P Gómez; Juan G Del Castillo
Journal:  Eur J Emerg Med       Date:  2021-06-01       Impact factor: 4.106

4.  Estimation of Admission D-dimer Cut-off Value to Predict Venous Thrombotic Events in Hospitalized COVID-19 Patients: Analysis of the SEMI-COVID-19 Registry.

Authors:  Carles García-Cervera; Vicente Giner-Galvañ; Philip Wikman-Jorgensen; Jaime Laureiro; Manuel Rubio-Rivas; Anthony Gurjian Arena; Francisco Arnalich-Fernandez; José Luis Beato Pérez; Juan Antonio Vargas Núñez; Jesús Javier González Igual; Jesús Díez-Manglano; Manuel Méndez Bailón; María José García Blanco; Santiago J Freire Castro; Judit Aranda Lobo; Luis Manzano; Jeffrey Oskar Magallanes Gamboa; Luis Arribas Pérez; Julio González Moraleja; Ruth Calderón Hernaiz; Javier García Alegría; Amara González Noya; Ricardo Gómez Huelgas; Carlos Lumbreras Bermejo; Juan Miguel Antón Santos
Journal:  J Gen Intern Med       Date:  2021-07-21       Impact factor: 6.473

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.